Newsletter
Approval Launch
News filed under Approval/Launch, newest first.
Showing 6–10 of 10 stories
Top story
Lupin Receives U.S. FDA Approval for Sodium Zirconium Cyclosilicate Oral Suspension
New Generic Treatment Approved for Hyperkalemia in Adults Lupin Limited has received approval fro...
Read story
Merck Seeks FDA Approval to Expand Enflonsia Use for High-Risk Children During Their Second RSV Season
FDA Accepts Supplemental Application for Enflonsia Merck, known as MSD outside the United States...
Read story
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of...
Read story
Triquetra Health Launches BioActive Vitamin B1 Clinical Strength with Complete B1 Activation System
New Supplement Combines High-Dose Benfotiamine with Essential Cofactors Triquetra Health has anno...
Read story
Dr. Reddy’s Zoliflodacin Gets Thai FDA Approval for Gonorrhea Treatment
Nuzolvence becomes a new oral antibiotic option for uncomplicated urogenital gonorrhea Dr. Reddy&...
Read storyPage 2 of 2
